Weekly Roundup FDA approves Truvada for adolescents at risk of HIV May 23rd, 2018 The US Food and Drug Administration (FDA) has expanded the approval of Truvada (tenofovir disoproxil fumarate/emtricitabine) as pre-exposure prophylaxis (PrEP) against...